Giant Cell Tumor — Trials

Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06239272	NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)	recruiting	Phase 1 / Phase 2	139	St. Jude Children's Research HospitalOTHER	1	Aug 3, 2026	clinicaltrials
NCT03069469	Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor	active not recruiting	Phase 1 / Phase 2	120	Deciphera Pharmaceuticals, LLCINDUSTRY	9	Jun 25, 2026	clinicaltrials
NCT04192344	A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor	recruiting	Phase 1	276	Abbisko Therapeutics Co, LtdINDUSTRY	2	Mar 19, 2026	clinicaltrials
NCT06647901

Data updated 22 days agoSource updated Aug 3, 2026source: clinicaltrials